Purpose Although obesity has been associated with improved survival on dialysis, its effects on renal transplantation outcomes remain unclear. Herein we aimed to evaluate the effect of obesity on posttransplantation complications. Results We included 180 patients, 34 (18%) were obese (body mass index >30 kg/m 2 ) and 146 were lean.Obese patients were more likely to develope renal artery stenosis (17.6% vs 2.8%, p < 0.001), hematoma (47.9% vs 17.6, p = 0.009), wound complications (64.7% vs 9.6%, P < 0.001) and renal vein thrombosis(2% vs 0%, p < 0.001). Urologic complications consisting ureteral, ureteropelvic and ureterovesicular junction stenosis, wound bleeding, urinary leakage and renal artery thrombosis and also hospitalization time were found similar between the two groups. 2 year patiets and graft survival were not statististically different.
Introduction
The prevalence of obesity in patients with end-stage renal disease (ESRD) is increasing rapidly [1, 2] . In 2003, 60% of the renal transplant candidates in the United States were either obese or overweight [3] . Kidney transplantation, in contradistinction to dialysis, improves the quality of life and adds years of life to patients with end-stage renal disease (ESRD) [4] [5] [6] . Although obesity has been associated with improved survival on dialysis in comparison to nonobese patients, but its effects on renal transplant outcomes remain unclear. Urinary complications are common following renal transplantation. Some authors report that the outcomes for obese kidney transplant recipients are inferior to those of non-obese recipients [7] [8] [9] [10] [11] [12] [13] whereas others report no difference in outcomes [14] [15] [16] [17] . This may be related in part to selection of the study populations, but most reports do not differentiate between obese patients (BMI between 25 and 30 kg/m 2 ) and morbidly obese patients (BMI > 35 kg/ m 2 ). The World Health Organization (WHO) classification of obesity is determined by the body mass index (BMI), which is defined as weight in kilograms (kg) divided by height in meters squared (m 2 ). Using this calculation, a BMI of 18.5-24.9 kg/m 2 represents normal weight, a BMI of 25-29.9 kg/m 2 represents overweight, and a BMI greater than 30 kg/m 2 represents obesity. Obesity affects at least 20% of the adult population in developed ORIGINAL ARTICLE countries and its incidence is continuing to increase [18] . The aim of this study is to evaluate the impact of recipients obesity on urologic complications in unrelated living donor kidney transplants. Exclusion criteria included multiorgan transplantation or a history of prior renal transplantation and age <15 years old, leaving a total of 180 persons classified as non-obese (lean) or obese. End to-end arterial anastomosis was performed between renal transplanted artery and the internal iliac artery. The renal vein was anastomosed to external iliac vein with an End-to-side anastomosis. The ureters were anastomosed by using anterior Lich technique and stenting was carried out in all ureters which were removed after two weeks. A triple immunosuppressive protocol therapy including Cyclosporine, Mycophenolate Mefotil, and Prednisolone was administred for all recipients.
Patients and methods

An analytic
The patients were followed for two years. In the database information was stored about recipient age and sex, donor age and sex, vascular complications, lymphocoel, haemorrhage, urinary leakage and ureteral stenosis, wound complications (infections and dehiscences), delayed graft function (DGF); (defined as the need for dialysis in the first week after renal transplantation) and BMI at the time of transplantation.
Statistical analysis
Data were shown as means ± SD. Graft survival was evaluated by the Kaplan-Meier method. Univariate comparison between Kaplan-Meier curves of the two groups was evaluated by Breslow statistics and log rank analysis. The statistical significance of differences between proportions was determined by chi-square analysis with Yates correction. Significance was defined as p < 0.05. respectively. There were 70 women (39%) and 110 men (61%) underwent renal trasplantation. Mean age of recipients and donors were 39.8 ± 14.9 (ranged 15 to 77) and 29.3 ± 6.2 years old (ranged 21 to 34), respectively. All of our living kidney donors were HLA-mismatched unrelated donors. Patients' demographic characteristics are shown in Table 1 . Older recipients were related to experience more risk for renal artery stenosis and hematoma (p = 0.002 and 0.03 respectively). Obese patients were more likely to experience renal artery stenosis (RAS) (17.6% vs 2.8%, P < 0.001). Logistic regression model showed a significant difference for the evaluation of BMI as a risk factor for hematoma (17.6% vs 48%, p = 0.009) and wound complications (64.7% vs 9.6%, p < 0.001) also there were a significant difference of renal vein thrombosis (RVT) between obese (2%) and non-obese group in which none of the patients had renal vein thrombosis (p < 0.05). As demonstrated in Table 2 there were no significant differences between the two groups with respect to DGF, ureteropelvic obstruction, UVJ obstruction, wound bleeding and urinary leakage, renal artery thrombosis and hospitalization time (p=No significant). During 2-year follow up no deaths had been observed in recipients. Graft survival rate in the obese patients was not significantly lower than that in lean kidney recipients (94.1% vs 96.7%; P = .42) 
Results
During
